Literature DB >> 34141078

Novel Bromodomain BRD4 Inhibitors for Treating Cancer.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 34141078      PMCID： PMC8201755          DOI： 10.1021/acsmedchemlett.1c00281

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  5 in total

Review 1.  Novel strategies targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery.

Authors:  Dailin Liang; Yifan Yu; Zonghui Ma
Journal:  Eur J Med Chem       Date:  2020-05-11       Impact factor: 6.514

Review 2.  Bromodomain-containing protein 4 and its role in cardiovascular diseases.

Authors:  Liang Li; Wei Xie; Yu Gui; Xi-Long Zheng
Journal:  J Cell Physiol       Date:  2020-12-20       Impact factor: 6.384

Review 3.  Domain-selective targeting of BET proteins in cancer and immunological diseases.

Authors:  Massimo Petretich; Emmanuel H Demont; Paola Grandi
Journal:  Curr Opin Chem Biol       Date:  2020-07-30       Impact factor: 8.822

Review 4.  The emerging role of BET inhibitors in breast cancer.

Authors:  Angeliki Andrikopoulou; Michalis Liontos; Konstantinos Koutsoukos; Meletios-Athanasios Dimopoulos; Flora Zagouri
Journal:  Breast       Date:  2020-08-13       Impact factor: 4.380

Review 5.  Inhibitors of bromodomain and extra-terminal proteins for treating multiple human diseases.

Authors:  Ewelina Kulikowski; Brooke D Rakai; Norman C W Wong
Journal:  Med Res Rev       Date:  2020-09-14       Impact factor: 12.944
  5 in total
  2 in total

1.  Virtual Special Issue: Epigenetics 2022.

Authors:  Courtney C Aldrich; Félix Calderón; Stuart J Conway; Chuan He; Jacob M Hooker; Donna M Huryn; Craig W Lindsley; Dennis C Liotta; Christa E Müller
Journal:  ACS Pharmacol Transl Sci       Date:  2022-09-09

2.  Virtual Special Issue: Epigenetics 2022.

Authors:  Courtney C Aldrich; Félix Calderón; Stuart J Conway; Chuan He; Jacob M Hooker; Donna M Huryn; Craig W Lindsley; Dennis C Liotta; Christa E Müller
Journal:  ACS Med Chem Lett       Date:  2022-10-13       Impact factor: 4.632
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.